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Abstract
© 2015,  Spyropoulos-Antonakakis  et  al.;  licensee  Springer.  Photodynamic  therapy  (PDT)
involves the action of  photons on photosensitive molecules,  where atomic  oxygen or  OH−
molecular  species  are  locally  released  on  pathogenic  human  cells,  which  are  mainly
carcinogenic,  thus  causing  cell  necrosis.  The  efficacy  of  PDT  depends  on  the  local
nanothermodynamic conditions near the cell/nanodrug system that control both the level of
intracellular translocation of nanoparticles in the pathogenic cell and their agglomeration on the
cell  membrane.  Dendrimers  are considered one of  the most  effective and promising drug
carriers because of  their  relatively low toxicity and negligible activation of  complementary
reactions. Polyamidoamine (PAMAM) dendrite delivery of PDT agents has been investigated in
the last  few years  for  tumour selectivity,  retention,  pharmacokinetics  and water  solubility.
Nevertheless, their use as drug carriers of photosensitizing molecules in PDT for cardiovascular
disease,  targeting the selective necrosis of  macrophage cells  responsible for atheromatous
plaque  growth,  has  never  been  investigated.  Furthermore,  the  level  of  aggregation,
translocation  and  nanodrug  delivery  efficacy  of  PAMAM  dendrimers  or  PAMAM/zinc
phthalocyanine (ZnPc) conjugates on human atheromatous tissue and endothelial cells is still
unknown. In this work, the aggregation of PAMAM zero generation dendrimers (G0) acting as
drug delivery carriers, as well as conjugated G0 PAMAM dendrimers with a ZnPc photosensitizer,
to symptomatic and asymptomatic human carotid tissues was investigated by using atomic
force microscopy (AFM). For the evaluation of the texture characteristics of the AFM images,
statistical surface morphological and fractal analytical methodologies and Minkowski functionals
were used. All statistical quantities showed that the deposition of nanodrug carriers on healthy
tissue has an inverse impact when comparing to the deposition on atheromatous tissue with
different aggregation features between G0 and G0/ZnPc nanoparticles and with considerably
larger G0/ZnPc aggregations on the atheromatous plaque. The results highlight the importance
of using PAMAM dendrimer carriers as a novel and promising PDT platform for atherosclerosis
therapies.
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